Trinity Financial Advisors LLC Cuts Stock Holdings in Axon Enterprise, Inc $AXON

Trinity Financial Advisors LLC decreased its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 32.8% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 409 shares of the biotechnology company’s stock after selling 200 shares during the period. Trinity Financial Advisors LLC’s holdings in Axon Enterprise were worth $339,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Fourth Dimension Wealth LLC purchased a new position in shares of Axon Enterprise during the fourth quarter valued at approximately $30,000. TCTC Holdings LLC lifted its holdings in Axon Enterprise by 75.0% during the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock worth $29,000 after acquiring an additional 24 shares during the period. Bartlett & CO. Wealth Management LLC lifted its holdings in Axon Enterprise by 132.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock worth $31,000 after acquiring an additional 33 shares during the period. Catalyst Capital Advisors LLC bought a new stake in Axon Enterprise during the first quarter worth $32,000. Finally, Banque Transatlantique SA bought a new stake in Axon Enterprise during the first quarter worth $31,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Activity at Axon Enterprise

In related news, CAO Jennifer H. Mak sold 75 shares of the business’s stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $723.50, for a total transaction of $54,262.50. Following the sale, the chief accounting officer directly owned 15,080 shares in the company, valued at approximately $10,910,380. The trade was a 0.49% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Jeffrey C. Kunins sold 7,891 shares of the business’s stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $750.10, for a total value of $5,919,039.10. Following the sale, the insider owned 144,538 shares in the company, valued at approximately $108,417,953.80. The trade was a 5.18% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 44,790 shares of company stock worth $34,304,947 in the last 90 days. 4.40% of the stock is owned by company insiders.

Axon Enterprise Stock Performance

Shares of AXON opened at $756.13 on Friday. The firm has a market cap of $59.36 billion, a PE ratio of 186.70, a PEG ratio of 27.57 and a beta of 1.40. The stock’s fifty day moving average price is $761.10 and its two-hundred day moving average price is $687.25. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71. Axon Enterprise, Inc has a 1 year low of $375.71 and a 1 year high of $885.91.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.58. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The firm had revenue of $668.54 million for the quarter, compared to analyst estimates of $641.77 million. During the same period in the previous year, the company posted $1.20 earnings per share. The business’s revenue was up 32.6% on a year-over-year basis. Axon Enterprise has set its FY 2025 guidance at EPS. On average, equities research analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on AXON. Zacks Research lowered Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 2nd. Northland Securities set a $800.00 price target on Axon Enterprise in a report on Tuesday, August 5th. Bank of America lifted their price target on Axon Enterprise from $895.00 to $1,000.00 and gave the stock a “buy” rating in a report on Wednesday, August 6th. Raymond James Financial reiterated an “outperform” rating and set a $855.00 price target (up from $645.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Finally, Craig Hallum upgraded Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 price target on the stock in a report on Tuesday, August 5th. Thirteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $837.69.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.